"SynthethicMR is currently in a period of slow sales development and Q4 sales were disappointing, down 31% y/y and a large miss from our estimates. It is investing in its sales organisation in order to secure long-term sales growth for its MRI software. We see potential for these investments to yield results in 2020."

Link to commissioned research below.

Länk till analysen